Global Intramuscular Drug Delivery Market Research Report 2023

Publisher Name :
Date: 09-Mar-2023
No. of pages: 92
Inquire Before Buying

Highlights

The global Intramuscular Drug Delivery market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Intramuscular Drug Delivery is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Intramuscular Drug Delivery is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Intramuscular Drug Delivery in Infectious Disease is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Intramuscular Drug Delivery include Antares Pharma, Eli Lily, Galaxo, HMD pharmaceuticals, Inovio Pharmaceuticals, Merck, Novartis, Pacira Pharmaceuticals and Pfizer, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Intramuscular Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intramuscular Drug Delivery.

The Intramuscular Drug Delivery market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Intramuscular Drug Delivery market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Intramuscular Drug Delivery companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

By Company

- Antares Pharma

- Eli Lily

- Galaxo

- HMD pharmaceuticals

- Inovio Pharmaceuticals

- Merck

- Novartis

- Pacira Pharmaceuticals

- Pfizer

- Pharmajet

- Teva Pharmaceutical

Segment by Type

- Drug Molecule

- Delivery Devices

Segment by Application

- Infectious Disease

- Oncology

- Autoimmune Diseases

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Intramuscular Drug Delivery companies' competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

Global Intramuscular Drug Delivery Market Research Report 2023

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Intramuscular Drug Delivery Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Drug Molecule
1.2.3 Delivery Devices
1.3 Market by Application
1.3.1 Global Intramuscular Drug Delivery Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Infectious Disease
1.3.3 Oncology
1.3.4 Autoimmune Diseases
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Intramuscular Drug Delivery Market Perspective (2018-2029)
2.2 Intramuscular Drug Delivery Growth Trends by Region
2.2.1 Global Intramuscular Drug Delivery Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Intramuscular Drug Delivery Historic Market Size by Region (2018-2023)
2.2.3 Intramuscular Drug Delivery Forecasted Market Size by Region (2024-2029)
2.3 Intramuscular Drug Delivery Market Dynamics
2.3.1 Intramuscular Drug Delivery Industry Trends
2.3.2 Intramuscular Drug Delivery Market Drivers
2.3.3 Intramuscular Drug Delivery Market Challenges
2.3.4 Intramuscular Drug Delivery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Intramuscular Drug Delivery Players by Revenue
3.1.1 Global Top Intramuscular Drug Delivery Players by Revenue (2018-2023)
3.1.2 Global Intramuscular Drug Delivery Revenue Market Share by Players (2018-2023)
3.2 Global Intramuscular Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Intramuscular Drug Delivery Revenue
3.4 Global Intramuscular Drug Delivery Market Concentration Ratio
3.4.1 Global Intramuscular Drug Delivery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Intramuscular Drug Delivery Revenue in 2022
3.5 Intramuscular Drug Delivery Key Players Head office and Area Served
3.6 Key Players Intramuscular Drug Delivery Product Solution and Service
3.7 Date of Enter into Intramuscular Drug Delivery Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Intramuscular Drug Delivery Breakdown Data by Type
4.1 Global Intramuscular Drug Delivery Historic Market Size by Type (2018-2023)
4.2 Global Intramuscular Drug Delivery Forecasted Market Size by Type (2024-2029)
5 Intramuscular Drug Delivery Breakdown Data by Application
5.1 Global Intramuscular Drug Delivery Historic Market Size by Application (2018-2023)
5.2 Global Intramuscular Drug Delivery Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Intramuscular Drug Delivery Market Size (2018-2029)
6.2 North America Intramuscular Drug Delivery Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Intramuscular Drug Delivery Market Size by Country (2018-2023)
6.4 North America Intramuscular Drug Delivery Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Intramuscular Drug Delivery Market Size (2018-2029)
7.2 Europe Intramuscular Drug Delivery Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Intramuscular Drug Delivery Market Size by Country (2018-2023)
7.4 Europe Intramuscular Drug Delivery Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Intramuscular Drug Delivery Market Size (2018-2029)
8.2 Asia-Pacific Intramuscular Drug Delivery Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Intramuscular Drug Delivery Market Size by Region (2018-2023)
8.4 Asia-Pacific Intramuscular Drug Delivery Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Intramuscular Drug Delivery Market Size (2018-2029)
9.2 Latin America Intramuscular Drug Delivery Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Intramuscular Drug Delivery Market Size by Country (2018-2023)
9.4 Latin America Intramuscular Drug Delivery Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Intramuscular Drug Delivery Market Size (2018-2029)
10.2 Middle East & Africa Intramuscular Drug Delivery Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Intramuscular Drug Delivery Market Size by Country (2018-2023)
10.4 Middle East & Africa Intramuscular Drug Delivery Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Antares Pharma
11.1.1 Antares Pharma Company Detail
11.1.2 Antares Pharma Business Overview
11.1.3 Antares Pharma Intramuscular Drug Delivery Introduction
11.1.4 Antares Pharma Revenue in Intramuscular Drug Delivery Business (2018-2023)
11.1.5 Antares Pharma Recent Development
11.2 Eli Lily
11.2.1 Eli Lily Company Detail
11.2.2 Eli Lily Business Overview
11.2.3 Eli Lily Intramuscular Drug Delivery Introduction
11.2.4 Eli Lily Revenue in Intramuscular Drug Delivery Business (2018-2023)
11.2.5 Eli Lily Recent Development
11.3 Galaxo
11.3.1 Galaxo Company Detail
11.3.2 Galaxo Business Overview
11.3.3 Galaxo Intramuscular Drug Delivery Introduction
11.3.4 Galaxo Revenue in Intramuscular Drug Delivery Business (2018-2023)
11.3.5 Galaxo Recent Development
11.4 HMD pharmaceuticals
11.4.1 HMD pharmaceuticals Company Detail
11.4.2 HMD pharmaceuticals Business Overview
11.4.3 HMD pharmaceuticals Intramuscular Drug Delivery Introduction
11.4.4 HMD pharmaceuticals Revenue in Intramuscular Drug Delivery Business (2018-2023)
11.4.5 HMD pharmaceuticals Recent Development
11.5 Inovio Pharmaceuticals
11.5.1 Inovio Pharmaceuticals Company Detail
11.5.2 Inovio Pharmaceuticals Business Overview
11.5.3 Inovio Pharmaceuticals Intramuscular Drug Delivery Introduction
11.5.4 Inovio Pharmaceuticals Revenue in Intramuscular Drug Delivery Business (2018-2023)
11.5.5 Inovio Pharmaceuticals Recent Development
11.6 Merck
11.6.1 Merck Company Detail
11.6.2 Merck Business Overview
11.6.3 Merck Intramuscular Drug Delivery Introduction
11.6.4 Merck Revenue in Intramuscular Drug Delivery Business (2018-2023)
11.6.5 Merck Recent Development
11.7 Novartis
11.7.1 Novartis Company Detail
11.7.2 Novartis Business Overview
11.7.3 Novartis Intramuscular Drug Delivery Introduction
11.7.4 Novartis Revenue in Intramuscular Drug Delivery Business (2018-2023)
11.7.5 Novartis Recent Development
11.8 Pacira Pharmaceuticals
11.8.1 Pacira Pharmaceuticals Company Detail
11.8.2 Pacira Pharmaceuticals Business Overview
11.8.3 Pacira Pharmaceuticals Intramuscular Drug Delivery Introduction
11.8.4 Pacira Pharmaceuticals Revenue in Intramuscular Drug Delivery Business (2018-2023)
11.8.5 Pacira Pharmaceuticals Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Detail
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Intramuscular Drug Delivery Introduction
11.9.4 Pfizer Revenue in Intramuscular Drug Delivery Business (2018-2023)
11.9.5 Pfizer Recent Development
11.10 Pharmajet
11.10.1 Pharmajet Company Detail
11.10.2 Pharmajet Business Overview
11.10.3 Pharmajet Intramuscular Drug Delivery Introduction
11.10.4 Pharmajet Revenue in Intramuscular Drug Delivery Business (2018-2023)
11.10.5 Pharmajet Recent Development
11.11 Teva Pharmaceutical
11.11.1 Teva Pharmaceutical Company Detail
11.11.2 Teva Pharmaceutical Business Overview
11.11.3 Teva Pharmaceutical Intramuscular Drug Delivery Introduction
11.11.4 Teva Pharmaceutical Revenue in Intramuscular Drug Delivery Business (2018-2023)
11.11.5 Teva Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Intramuscular Drug Delivery Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Drug Molecule
Table 3. Key Players of Delivery Devices
Table 4. Global Intramuscular Drug Delivery Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Intramuscular Drug Delivery Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Intramuscular Drug Delivery Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Intramuscular Drug Delivery Market Share by Region (2018-2023)
Table 8. Global Intramuscular Drug Delivery Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Intramuscular Drug Delivery Market Share by Region (2024-2029)
Table 10. Intramuscular Drug Delivery Market Trends
Table 11. Intramuscular Drug Delivery Market Drivers
Table 12. Intramuscular Drug Delivery Market Challenges
Table 13. Intramuscular Drug Delivery Market Restraints
Table 14. Global Intramuscular Drug Delivery Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Intramuscular Drug Delivery Market Share by Players (2018-2023)
Table 16. Global Top Intramuscular Drug Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intramuscular Drug Delivery as of 2022)
Table 17. Ranking of Global Top Intramuscular Drug Delivery Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Intramuscular Drug Delivery Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Intramuscular Drug Delivery Product Solution and Service
Table 21. Date of Enter into Intramuscular Drug Delivery Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Intramuscular Drug Delivery Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Intramuscular Drug Delivery Revenue Market Share by Type (2018-2023)
Table 25. Global Intramuscular Drug Delivery Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Intramuscular Drug Delivery Revenue Market Share by Type (2024-2029)
Table 27. Global Intramuscular Drug Delivery Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Intramuscular Drug Delivery Revenue Market Share by Application (2018-2023)
Table 29. Global Intramuscular Drug Delivery Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Intramuscular Drug Delivery Revenue Market Share by Application (2024-2029)
Table 31. North America Intramuscular Drug Delivery Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Intramuscular Drug Delivery Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Intramuscular Drug Delivery Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Intramuscular Drug Delivery Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Intramuscular Drug Delivery Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Intramuscular Drug Delivery Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Intramuscular Drug Delivery Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Intramuscular Drug Delivery Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Intramuscular Drug Delivery Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Intramuscular Drug Delivery Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Intramuscular Drug Delivery Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Intramuscular Drug Delivery Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Intramuscular Drug Delivery Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Intramuscular Drug Delivery Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Intramuscular Drug Delivery Market Size by Country (2024-2029) & (US$ Million)
Table 46. Antares Pharma Company Detail
Table 47. Antares Pharma Business Overview
Table 48. Antares Pharma Intramuscular Drug Delivery Product
Table 49. Antares Pharma Revenue in Intramuscular Drug Delivery Business (2018-2023) & (US$ Million)
Table 50. Antares Pharma Recent Development
Table 51. Eli Lily Company Detail
Table 52. Eli Lily Business Overview
Table 53. Eli Lily Intramuscular Drug Delivery Product
Table 54. Eli Lily Revenue in Intramuscular Drug Delivery Business (2018-2023) & (US$ Million)
Table 55. Eli Lily Recent Development
Table 56. Galaxo Company Detail
Table 57. Galaxo Business Overview
Table 58. Galaxo Intramuscular Drug Delivery Product
Table 59. Galaxo Revenue in Intramuscular Drug Delivery Business (2018-2023) & (US$ Million)
Table 60. Galaxo Recent Development
Table 61. HMD pharmaceuticals Company Detail
Table 62. HMD pharmaceuticals Business Overview
Table 63. HMD pharmaceuticals Intramuscular Drug Delivery Product
Table 64. HMD pharmaceuticals Revenue in Intramuscular Drug Delivery Business (2018-2023) & (US$ Million)
Table 65. HMD pharmaceuticals Recent Development
Table 66. Inovio Pharmaceuticals Company Detail
Table 67. Inovio Pharmaceuticals Business Overview
Table 68. Inovio Pharmaceuticals Intramuscular Drug Delivery Product
Table 69. Inovio Pharmaceuticals Revenue in Intramuscular Drug Delivery Business (2018-2023) & (US$ Million)
Table 70. Inovio Pharmaceuticals Recent Development
Table 71. Merck Company Detail
Table 72. Merck Business Overview
Table 73. Merck Intramuscular Drug Delivery Product
Table 74. Merck Revenue in Intramuscular Drug Delivery Business (2018-2023) & (US$ Million)
Table 75. Merck Recent Development
Table 76. Novartis Company Detail
Table 77. Novartis Business Overview
Table 78. Novartis Intramuscular Drug Delivery Product
Table 79. Novartis Revenue in Intramuscular Drug Delivery Business (2018-2023) & (US$ Million)
Table 80. Novartis Recent Development
Table 81. Pacira Pharmaceuticals Company Detail
Table 82. Pacira Pharmaceuticals Business Overview
Table 83. Pacira Pharmaceuticals Intramuscular Drug Delivery Product
Table 84. Pacira Pharmaceuticals Revenue in Intramuscular Drug Delivery Business (2018-2023) & (US$ Million)
Table 85. Pacira Pharmaceuticals Recent Development
Table 86. Pfizer Company Detail
Table 87. Pfizer Business Overview
Table 88. Pfizer Intramuscular Drug Delivery Product
Table 89. Pfizer Revenue in Intramuscular Drug Delivery Business (2018-2023) & (US$ Million)
Table 90. Pfizer Recent Development
Table 91. Pharmajet Company Detail
Table 92. Pharmajet Business Overview
Table 93. Pharmajet Intramuscular Drug Delivery Product
Table 94. Pharmajet Revenue in Intramuscular Drug Delivery Business (2018-2023) & (US$ Million)
Table 95. Pharmajet Recent Development
Table 96. Teva Pharmaceutical Company Detail
Table 97. Teva Pharmaceutical Business Overview
Table 98. Teva Pharmaceutical Intramuscular Drug Delivery Product
Table 99. Teva Pharmaceutical Revenue in Intramuscular Drug Delivery Business (2018-2023) & (US$ Million)
Table 100. Teva Pharmaceutical Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Intramuscular Drug Delivery Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Intramuscular Drug Delivery Market Share by Type: 2022 VS 2029
Figure 3. Drug Molecule Features
Figure 4. Delivery Devices Features
Figure 5. Global Intramuscular Drug Delivery Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Intramuscular Drug Delivery Market Share by Application: 2022 VS 2029
Figure 7. Infectious Disease Case Studies
Figure 8. Oncology Case Studies
Figure 9. Autoimmune Diseases Case Studies
Figure 10. Intramuscular Drug Delivery Report Years Considered
Figure 11. Global Intramuscular Drug Delivery Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Intramuscular Drug Delivery Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Intramuscular Drug Delivery Market Share by Region: 2022 VS 2029
Figure 14. Global Intramuscular Drug Delivery Market Share by Players in 2022
Figure 15. Global Top Intramuscular Drug Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intramuscular Drug Delivery as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Intramuscular Drug Delivery Revenue in 2022
Figure 17. North America Intramuscular Drug Delivery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Intramuscular Drug Delivery Market Share by Country (2018-2029)
Figure 19. United States Intramuscular Drug Delivery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Intramuscular Drug Delivery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Intramuscular Drug Delivery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Intramuscular Drug Delivery Market Share by Country (2018-2029)
Figure 23. Germany Intramuscular Drug Delivery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Intramuscular Drug Delivery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Intramuscular Drug Delivery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Intramuscular Drug Delivery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Intramuscular Drug Delivery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Intramuscular Drug Delivery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Intramuscular Drug Delivery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Intramuscular Drug Delivery Market Share by Region (2018-2029)
Figure 31. China Intramuscular Drug Delivery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Intramuscular Drug Delivery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Intramuscular Drug Delivery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Intramuscular Drug Delivery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Intramuscular Drug Delivery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Intramuscular Drug Delivery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Intramuscular Drug Delivery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Intramuscular Drug Delivery Market Share by Country (2018-2029)
Figure 39. Mexico Intramuscular Drug Delivery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Intramuscular Drug Delivery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Intramuscular Drug Delivery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Intramuscular Drug Delivery Market Share by Country (2018-2029)
Figure 43. Turkey Intramuscular Drug Delivery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Intramuscular Drug Delivery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Antares Pharma Revenue Growth Rate in Intramuscular Drug Delivery Business (2018-2023)
Figure 46. Eli Lily Revenue Growth Rate in Intramuscular Drug Delivery Business (2018-2023)
Figure 47. Galaxo Revenue Growth Rate in Intramuscular Drug Delivery Business (2018-2023)
Figure 48. HMD pharmaceuticals Revenue Growth Rate in Intramuscular Drug Delivery Business (2018-2023)
Figure 49. Inovio Pharmaceuticals Revenue Growth Rate in Intramuscular Drug Delivery Business (2018-2023)
Figure 50. Merck Revenue Growth Rate in Intramuscular Drug Delivery Business (2018-2023)
Figure 51. Novartis Revenue Growth Rate in Intramuscular Drug Delivery Business (2018-2023)
Figure 52. Pacira Pharmaceuticals Revenue Growth Rate in Intramuscular Drug Delivery Business (2018-2023)
Figure 53. Pfizer Revenue Growth Rate in Intramuscular Drug Delivery Business (2018-2023)
Figure 54. Pharmajet Revenue Growth Rate in Intramuscular Drug Delivery Business (2018-2023)
Figure 55. Teva Pharmaceutical Revenue Growth Rate in Intramuscular Drug Delivery Business (2018-2023)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
  • Global Gold Nanoparticles Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 121
    Gold nanoparticles are particles with diameters in The 1-100nm range and have unique optical and physical properties. These unique optical-electronics properties have been researched and utilized in high technology applications such as organic photovoltaics, sensory probes, therapeutic agents, drug delivery in biological and medical applications, electronic conductors and catalysis. The optical and electronic properties of gold nanoparticles are tunable by changing The size, shape, surface chemi......
  • Global High Volume Subcutaneous Drug Delivery Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 109
    Market Overview of Global High Volume Subcutaneous Drug Delivery market: According to our latest research, the global High Volume Subcutaneous Drug Delivery market looks promising in the next 5 years. As of 2022, the global High Volume Subcutaneous Drug Delivery market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a dee......
  • Global Gold Nanoparticles Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134
    According to our LPI (LP Information) latest study, the global Gold Nanoparticles market size was valued at US$ 86 million in 2023. With growing demand in downstream market, the Gold Nanoparticles is forecast to a readjusted size of US$ 200.8 million by 2030 with a CAGR of 12.9% during review period. The research report highlights the growth potential of the global Gold Nanoparticles market. Gold Nanoparticles are expected to show stable growth in the future market. However, product diff......
  • Global Liposome Drug Delivery Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 123
    According to our LPI (LP Information) latest study, the global Liposome Drug Delivery market size was valued at US$ 3652.8 million in 2023. With growing demand in downstream market, the Liposome Drug Delivery is forecast to a readjusted size of US$ 8742.8 million by 2030 with a CAGR of 13.3% during review period. The research report highlights the growth potential of the global Liposome Drug Delivery market. Liposome Drug Delivery are expected to show stable growth in the future market. ......
  • Global Transdermal Drug Delivery System Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 127
    According to our LPI (LP Information) latest study, the global Transdermal Drug Delivery System market size was valued at US$ 14730 million in 2023. With growing demand in downstream market, the Transdermal Drug Delivery System is forecast to a readjusted size of US$ 36410 million by 2030 with a CAGR of 13.8% during review period. The research report highlights the growth potential of the global Transdermal Drug Delivery System market. Transdermal Drug Delivery System are expected to sho......
  • Global Liposomes Drug Delivery Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 117
    According to our LPI (LP Information) latest study, the global Liposomes Drug Delivery market size was valued at US$ 3262.7 million in 2023. With growing demand in downstream market, the Liposomes Drug Delivery is forecast to a readjusted size of US$ 6510.7 million by 2030 with a CAGR of 10.4% during review period. The research report highlights the growth potential of the global Liposomes Drug Delivery market. Liposomes Drug Delivery are expected to show stable growth in the future mark......
  • Global Gold Nanoparticles Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 129
    According to our (Global Info Research) latest study, the global Gold Nanoparticles market size was valued at USD 91 million in 2023 and is forecast to a readjusted size of USD 198.5 million by 2030 with a CAGR of 11.9% during review period. Gold nanoparticles are particles with diameters in the 1-100nm range and have unique optical and physical properties. These unique optical-electronics properties have been researched and utilized in high technology applications such as organic photov......
  • Global Polymers Drug Delivery Market Research Report 2023, Forecast to 2028
    Published: 27-Dec-2023        Price: US 2680 Onwards        Pages: 160
    Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drugs in the body. Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drug......
  • Global Polymers Drug Delivery Professional Survey Report 2023, Forecast to 2028
    Published: 27-Dec-2023        Price: US 3280 Onwards        Pages: 135
    Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drugs in the body. Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drug......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs